ISTH interim guidance on recognition and management of coagulopathy in COVID‐19

Abstract

Affiliations: 1 Department of Haematology, Manchester University Hospitals, Oxford road, Manchester, United Kingdom, 2 Tongji hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China, 3 Department of Acute and Critical Care Medicine, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan, 4 University of Milan Bicocca, Dept of Medicine and Surgery; Hospital Papa Giovanni, XXIII, Bergamo; Italy, 5 ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan. ITALY, 6 Department of Medicine and Cardio-metabolic Programme-NIHR UCLH/UCL BRC, University College London Hospitals NHS Foundation Trust, London, United Kingdom, 7 Director of Programs and Education, International Society on Thrombosis and Haemostasis 8 Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Keywords

CoagulopathyMedicineCoronavirus disease 2019 (COVID-19)InterimIntensive care medicineDiseaseOrgan dysfunctionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineInfectious disease (medical specialty)Sepsis

MeSH Terms

BetacoronavirusBiomarkersBlood Coagulation DisordersCOVID-19COVID-19 TestingClinical Laboratory TechniquesCoronavirus InfectionsFibrin Fibrinogen Degradation ProductsHumansPandemicsPlatelet CountPneumoniaViralProthrombin TimeSARS-CoV-2

Affiliated Institutions

Related Publications

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh , Robert W. Frenck , Ann R. Falsey +22 more

The safety and immunogenicity data from this U.S. phase 1 trial of two vaccine candidates in younger and older adults, added to earlier interim safety and immunogenicity data re...

2020 New England Journal of Medicine 2665 citations

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Qiurong Ruan , Kun Yang , Wenxia Wang +2 more

2020 Intensive Care Medicine 5089 citations

SARS in Hospital Emergency Room

Yee‐Chun Chen , Li‐Min Huang , Chang‐Chuan Chan +8 more

Thirty-one cases of severe acute respiratory syndrome (SARS) occurred after exposure in the emergency room at the National Taiwan University Hospital. The index patient was link...

2004 Emerging infectious diseases 161 citations

Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State

Matthew Arentz , Eric Yim , Lindy S. Klaff +4 more

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the disease it causes, coronavirus disease 2019 (COVID-19), is an emerging health threat.1 Until February 20...

2020 JAMA 2384 citations

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

Annemarie B Docherty , Ewen M Harrison , Christopher Green +22 more

Abstract Objective To characterise the clinical features of patients admitted to hospital with coronavirus disease 2019 (covid-19) in the United Kingdom during the growth phase ...

2020 BMJ 3559 citations

Publication Info

Year: 2020
Type: article
Volume: 18
Issue: 5
Pages: 1023-1026
Citations: 1974
Access: Closed

External Links

Download PDF (Free) View on DOI.org PubMed Semantic Scholar

Social Impact

Altmetric

ISTH interim guidance on recognition and management of coagulopathy in COVID‐19

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1974

OpenAlex

Influential

1437

CrossRef

Cite This

APA Style

                            
                                
                                    Jecko Thachil, 
                                
                                    Ning Tang, 
                                
                                    Satoshi Gando
                                
                                et al.
                            
                            (2020). 
                            ISTH interim guidance on recognition and management of coagulopathy in COVID‐19. 
                            Journal of Thrombosis and Haemostasis
                            , 18
                            (5)
                            , 1023-1026.
                            https://doi.org/10.1111/jth.14810
                        

Identifiers

DOI: 10.1111/jth.14810
PMID: 32338827
PMCID: PMC9906133

Data Quality

Data completeness: 86%